Table 1 Classification of the minimum inhibitory concentration of blood isolates identified in this study based on epidemiological cut-off values and clinical breakpoints
Species | Susceptibility | MIC values (μg/ml) | |||||
|---|---|---|---|---|---|---|---|
FLZ | VRZ | ITZ | AMB | MFG | ANF | ||
Candida tropicalis(n = 19) | <ECV | 12 | 10 | 13 | 19 | 19 | 19 |
>ECV | 7 | 9 | 5 | 0 | 0 | 0 | |
S | 13 | 15 | NA | NA | 19 | 19 | |
R | 6 | 4 | NA | NA | 0 | 0 | |
Candida albicans(n = 18) | <ECV | 17 | 17 | 18 | 18 | 18 | 18 |
>ECV | 1 | 1 | 0 | 0 | 0 | 0 | |
S | 18 | 18 | NA | NA | 18 | 18 | |
R | 0 | 0 | NA | NA | 0 | 0 | |
Candida parapsilosis(n = 18) | <ECV | 18 | 18 | 18 | 18 | 18 | 18 |
>ECV | 0 | 0 | 0 | 0 | 0 | 0 | |
S | 18 | 18 | NA | NA | 18 | 18 | |
R | 0 | 0 | NA | NA | 0 | 0 | |
Candida glabrata(n = 7) | <ECV | 7 | 7 | 7 | 7 | 6 | 7 |
>ECV | 0 | 0 | 0 | 0 | 1 | 0 | |
S | 7 | NA | NA | NA | 7 | 7 | |
R | 0 | NA | NA | NA | 0 | 0 | |
Candida dubliniensis(n = 1) | <ECV | 1 | 1 | 1 | 1 | 1 | 1 |
>ECV | 0 | 0 | 0 | 0 | 0 | 0 | |
Clavispora lusitaniae(n = 1) | <ECV | 1 | 1 | 1 | 1 | 1 | 1 |
>ECV | 0 | 0 | 0 | 0 | 0 | 0 | |
Lodderomyces elongiporous(n = 1) | NA | ≤0.125 | ≤0.03 | 0.03 | 0.06 | ≤0.0156 | ≤0.0156 |
Aureobasidium melanogenum(n = 1) | NA | 16 | 0.06 | 0.06 | 0.125 | 1 | 1 |